Showing results (21-30 of 81) with videos related to
Sort By:
Pageof 9
The Prostate|June 4, 2004
A prostate stem cell antigen-derived peptide immunogenic in HLA-A24- prostate cancer patientsSatoko Matsueda, Akihisa Yao, Yuki Ishihara, et al.Cancer Immunology, Immunotherapy : CII|August 29, 2006
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype allelesTakafumi Minami, Satoko Matsueda, Hiroko Takedatsu, et al.Cancer Immunology, Immunotherapy : CII|January 6, 2016
A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancerMasanori Noguchi, Fukuko Moriya, Noriko Koga, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|July 11, 2013
Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide VaccineShigeru Yutani, Nobukazu Komatsu, Satoko Matsueda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Pretreatment and Posttreatment Evaluations of Circulating Tumor Cells（CTC）in Patients with Metastatic Breast Cancer]Mina Okabe, Uhi Toh, Nobutaka Iwakuma, et al.BMC Cancer|December 31, 2013
A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling timeMasanori Noguchi, Fukuko Moriya, Shigetaka Suekane, et al.Plos One|February 6, 2014
Humoral immune responses to EGFR-derived peptides predict progression-free and overall survival of non-small cell lung cancer patients receiving gefitinibKoichi Azuma, Nobukazu Komatsu, Satoshi Hattori, et al.Journal for Immunotherapy of Cancer|February 1, 2022
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signalingKenichi Makino, Mark D Long, Ryutaro Kajihara, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Identification of epidermal growth factor receptor-derived peptides recognised by both cellular and humoral immune responses in HLA-A24+ non-small cell lung cancer patientsHiroki Shomura, Shigeki Shichijo, Nobukazu Komatsu, et al.Cancer Immunology, Immunotherapy : CII|February 1, 2007
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33Satoko Matsueda, Akira Yamada, Yukari Takao, et al.Pageof 9